Outcomes
| NDND ET group (n=37) | DAWN ET group (n=26) | P value (DAWN vs NDND) | DEFUSE-3 ET group (n=24) | P value (NDND vs DEFUSE-3) | NDND non-ET group (n=105) | |
| Procedural technique | ||||||
| Manual aspiration | 49% (18) | 8% (2) | <0.01 | 21% (5) | 0.01 | NA |
| Stent retriever | 51% (19) | 92% (24) | 79% (19) | NA | ||
| % TICI ≥2b | 89% (33) | 92% (24) | 0.67 | 88% (21) | 0.83 | NA |
| Outcomes | ||||||
| % Early neurological recovery | 24% (9) | 58% (15) | <0.01 | 46% (11) | 0.08 | 11% (12) |
| mRS 0–2 at 90 days | 30% (11) | 54% (14) | 0.054 | 38% (9) | 0.52 | 12% (13) |
| % sICH | 8% (3) | 4% (1) | 0.49 | 4% (1) | 0.54 | 5% (5) |
| Mortality | 24% (9) | 15% (4) | 0.38 | 13% (3) | 0.25 | 31% (33) |
mRS, modified Rankin Scale; NDND, non-DAWN non-DEFUSE-3 group; sICH, symptomatic intracerebral hemorrhage; TICI, Thrombolysis in Cerebral Infarction.